Miata short presentation mibbi

350 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
350
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Miata short presentation mibbi

  1. 1. The M inimal I nformation A bout T cell A ssays (MIATA) project has two main goals that will be addressed in a two-step approach: Mid-term goal of MIATA = Phase 1: Establishment of a minimal information reporting framework for human T cell immune monitoring methods in scientific publications .  Long-term goal of MIATA = Phase 2 : Based on its successful implementation and substantiated feasibility and usefulness for scientific publications, adapt the reporting framework for annotations of immune monitoring data sets from human studies for a central database , possibly in the context of a Human Immunity Project. This will have to include structured database vocabulary.  MIATA – Scope of Guidelines Dedicated Website: www.miataproject.org
  2. 2. MIATA – Level of Implementation (Phase 1) <ul><li>MIATA is still in the preparatory phase (not finalized) </li></ul><ul><li>Several Journal editors have been approached and have expressed great interest </li></ul><ul><li>The core team expects that the final MIATA Guidelines will be published in Q4/2011 </li></ul><ul><li>For phase 1 supporting software or a CV/ontology are not needed </li></ul>Level of Acceptance <ul><li>Published at website </li></ul><ul><li>Announced in Immunity </li></ul><ul><li>(2009, Vol. 31, p527) </li></ul>Publication of Guidelines only after broad acceptance has been achieved <ul><li>Available at website </li></ul><ul><li>Workshop Results published in CII </li></ul><ul><li>(2010 / PMID: 21080166) </li></ul><ul><li>Public Consultation Period </li></ul><ul><li>Consensus Workshop </li></ul><ul><li>Webinars </li></ul>Guidelines Version 0.0 Guidelines Version 1.0 Guidelines Version 2.0 <ul><li>Public Consultation Period </li></ul><ul><li>Consensus Workshop planed for June 2011 </li></ul>
  3. 3. MIATA – Status, Contributors, Funding <ul><li>Status: </li></ul><ul><li>Project is still in a „long“ preparatory phase. A finalized and well-vetted version of the guideline for reporting in scientific publications should be available by end of 2011 </li></ul><ul><li>Contributors: </li></ul><ul><li>Core Team (n=15) </li></ul><ul><li>Invited experts (n=25) </li></ul><ul><li>Comments from public consultation period (n=80) </li></ul><ul><li>Funding: </li></ul><ul><li>Te project has been supported by the Cancer Research Institute‘s Cancer Immunotherapy Consortium (CRI/CIC) and by the association for Cancer Immunotherapy‘s working group Cancer Immunotherapy Immunoguiding Program (CIMT/CIP) </li></ul>Final Consensus Workshop scheduled for June 2011 – FOCIS 2011

×